Navigation Links
Acute Measles Supresses HIV Replication

Replication of human immunodeficiency virus (HIV) is briefly suppressed during acute measles. A study of HIV-infected children found that HIV levels in the blood// were significantly lower while having measles compared to HIV-infected children who did not have measles.

"We were surprised by these findings, because we expected to see HIV replication increase, not decrease with measles," says the study’s lead author William Moss, MD, MPH, assistant research professor of international health and molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health. For the study, Dr. Moss and his colleagues followed 100 children diagnosed with measles and HIV. The children’s HIV levels were measured from blood samples taken when they were admitted to the hospital for measles treatment. More samples were taken when the children were discharged from the hospital, and again 2 month later. They were compared with samples taken from HIV-infected children who did not have measles or other illnesses and with samples from children with measles, but not HIV.

"Measles is a very immunosuppressive virus. It results in many secondary infections and is a major cause of death among children. Our findings show that measles also triggers intense immune system activation that temporarily suppresses HIV," explains Dr. Moss
'"/>




Page: 1

Related medicine news :

1. Severe Acute respiratory Syndrome (SARS)
2. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
3. Acute Pancreatitis On The Rise Due To Alcohol Consumption
4. Promised Drug Doesnt Help Acute Heart Failure
5. Gene Fusion Test to screen children’s with Acute Lymphoblastic Leukemi
6. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
7. Acute Gastroenteritis Responds To Treatment With Either Gatorade Or Pedialyte
8. Acute Shortage Of Neurosurgeons In India: One Surgeon For Every 1 Million!
9. Acute Shortage Of Dentists in UK: Oral Care for Elders To Suffer A Setback
10. Acute Lymphoblastic Leukemia May Attain a 90% Cure Rate
11. Women Health : Acute Stress, A Shot in The Arm For Flu?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... York, New York (PRWEB) , ... ... ... International Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light ... announced it has entered into a definitive agreement to purchase Unitrans International ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry ... educational webinar, they will present the line of epMotion automated liquid handling system. ... you can automate everyday pipetting tasks. , Ideal for scientists and lab technicians ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a Houston area ... Texas, is launching a regional charity effort to provide publicity assistance and generate ... Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations that has ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... Boca Raton (PRWEB) , ... August 18, 2017 , ... ... is continuing to ramp up its marketing efforts with its product now available through ... hangover remedy to the public. The effervescent powdered drink is designed to quickly detox ...
Breaking Medicine News(10 mins):
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... , Aug. 7, 2017 Zimmer Biomet Holdings, ... healthcare, today announced that its Board of Directors has approved ... the third quarter of 2017. ... paid on or about October 27, 2017 to stockholders of ... 2017.  Future declarations of dividends are subject to approval of ...
Breaking Medicine Technology: